Salvage treatment after r-interferon alpha-2a in advanced neuroendocrine tumors.
Zilembo N, Buzzoni R, Bajetta E, Di Bartolomeo M, de Braud F, Castellani R, Maffioli L, Celio L, Villa E, Lorusso V, et al.
Zilembo N, et al. Among authors: celio l.
Acta Oncol. 1993;32(2):245-50. doi: 10.3109/02841869309083920.
Acta Oncol. 1993.
PMID: 8391833
Clinical Trial.